Galina Shamayeva
Overview
Explore the profile of Galina Shamayeva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zacharski L, Shamayeva G, Chow B
Metallomics
. 2018 Jan;
10(2):264-277.
PMID: 29302655
Iron-catalyzed oxygen-free radical-induced oxidative stress mediates the pathogenesis of diabetes and cardiovascular disease (CVD). Diabetics (n = 473) and non-diabetics (n = 804) with CVD entered into a randomized trial...
2.
Zacharski L, Shamayeva G, Chow B, DePalma R
Curr Diabetes Rev
. 2017 May;
13(4):428-436.
PMID: 28474556
Introduction: Type 2 diabetes (T2D) and cardiovascular disease (CVD) risk associate with ferritin and percent transferrin saturation (%TS) levels. However, increased risk has been observed at levels considered within the...
3.
Zacharski L, Shamayeva G, Chow B, DePalma R
J Health Care Poor Underserved
. 2016 May;
27(2):741-61.
PMID: 27180706
Oxidative stress from excess iron may contribute to racial health disparities. Previously we reported improved clinical outcomes with lower ferritin and higher percent transferrin saturation (%TS) levels in White but...
4.
Zacharski L, Shamayeva G, Chow B, DePalma R
J Health Care Poor Underserved
. 2015 Feb;
26(1):243-59.
PMID: 25702740
Elevated body iron (ferritin) levels may contribute to adverse health outcomes. Racial differences in iron measures and clinical outcomes were observed during an iron reduction trial in peripheral arterial disease....
5.
DePalma R, Zacharski L, Chow B, Shamayeva G, Hayes V
Vascular
. 2013 Mar;
21(4):233-41.
PMID: 23518844
A prospective randomized trial suggested that iron (ferritin) reduction improved outcomes in smokers. The present study reanalyzed the trial results in smokers compared with non-smokers. Randomization of 1262 men with...
6.
Zacharski L, DePalma R, Shamayeva G, Chow B
Am J Public Health
. 2013 Feb;
103(4):e105-12.
PMID: 23409890
Objectives: We postulated the existence of a statin-iron nexus by which statins improve cardiovascular disease outcomes at least partially by countering proinflammatory effects of excess iron stores. Methods: Using data...
7.
Zacharski L, Shamayeva G, Chow B
Am Heart J
. 2011 Nov;
162(5):949-957.e1.
PMID: 22093213
Background: Published results from a controlled clinical trial in patients with peripheral arterial disease found improved outcomes with iron (ferritin) reduction among middle-aged subjects but not the entire cohort. The...
8.
DePalma R, Hayes V, Chow B, Shamayeva G, May P, Zacharski L
J Vasc Surg
. 2010 Mar;
51(6):1498-503.
PMID: 20304584
Background: This study delineated correlations between ferritin, inflammatory biomarkers, and mortality in a cohort of 100 cancer-free patients with peripheral arterial disease (PAD) participating in the Veterans Affairs (VA) Cooperative...
9.
Zacharski L, Chow B, Howes P, Shamayeva G, Baron J, Dalman R, et al.
J Natl Cancer Inst
. 2008 Jul;
100(14):996-1002.
PMID: 18612130
Background: Excess iron has been implicated in cancer risk through increased iron-catalyzed free radical-mediated oxidative stress. Methods: A multicenter randomized, controlled, single-blinded clinical trial (VA Cooperative Study #410) tested the...
10.
Zacharski L, Chow B, Howes P, Shamayeva G, Baron J, Dalman R, et al.
JAMA
. 2007 Feb;
297(6):603-10.
PMID: 17299195
Context: Accumulation of iron in excess of physiologic requirements has been implicated in risk of cardiovascular disease because of increased iron-catalyzed free radical-mediated oxidative stress. Objective: To test the hypothesis...